GSI to take up 111 public good projects next fiscal

GSI to take up 111 public good projects next fiscal

For FY'24, a total of 966 standard programmes have been finalised by GSI across five missions

FPJ Web DeskUpdated: Saturday, February 11, 2023, 06:12 PM IST
article-image
GSI to take up 111 public good projects next fiscal | Image: GSI (Representative)

The Geological Survey of India (GSI) will take up 111 public health and public good geoscience activities during the next financial year, an official statement said.

For FY'24, a total of 966 standard programmes have been finalised by GSI across five missions.

According to the mines ministry, the emphasis is on baseline data generation and mineral exploration programs, with a special emphasis on strategic-critical and fertiliser minerals exploration.

Additional courses

Additionally, GSI will enrol in 115 courses to teach and enhance the capacity of its staff as well as outside officials, including geoscientists from several states.

One of the world's oldest survey organisations is GSI, which was established in 1851. GSI has made noteworthy contributions to the field of geosciences over the years and has continued to expand and diversify into numerous geoscientific endeavours.

RECENT STORIES

Canara Bank Net Profit Climbs To ₹5,155 Crore In Q3 FY26, Revenue Rises 10% YoY To ₹39,881 Crore
Canara Bank Net Profit Climbs To ₹5,155 Crore In Q3 FY26, Revenue Rises 10% YoY To ₹39,881 Crore
CBI Raids Multiple Locations In Kolkata Over ₹1,000 Crore Bank Fraud By Finance Company Promoters
CBI Raids Multiple Locations In Kolkata Over ₹1,000 Crore Bank Fraud By Finance Company Promoters
India’s Growth Potential Raised To 7%, Economic Survey 2025-26
India’s Growth Potential Raised To 7%, Economic Survey 2025-26
Budget Session Marks New Momentum For Viksit Bharat 2047, India-EU FTA Signals Bright Future For...
Budget Session Marks New Momentum For Viksit Bharat 2047, India-EU FTA Signals Bright Future For...
Gland Pharma Shares Surge Over 9%, Q3 FY26 Profit Rises 28% To ₹261 Crore
Gland Pharma Shares Surge Over 9%, Q3 FY26 Profit Rises 28% To ₹261 Crore